Zhugunissov K, Kilibayev S, Mambetaliyev M, Zakarya K, Kassenov M, Abduraimov Y
Front Vet Sci. 2021; 8:721023.
PMID: 34485443
PMC: 8415447.
DOI: 10.3389/fvets.2021.721023.
Mullbacher A, Blanden R
Immunogenetics. 2011; 7(1):551-61.
PMID: 21302107
DOI: 10.1007/BF01844044.
Xu R, Cohen M, Tang Y, Lazear E, Whitbeck J, Eisenberg R
J Exp Med. 2008; 205(4):981-92.
PMID: 18391063
PMC: 2292233.
DOI: 10.1084/jem.20071854.
Lobigs M, Blanden R, Mullbacher A
Immunol Rev. 1996; 152:5-19.
PMID: 8930665
PMC: 7165549.
DOI: 10.1111/j.1600-065x.1996.tb00908.x.
Gallichan W, Rosenthal K
J Exp Med. 1996; 184(5):1879-90.
PMID: 8920875
PMC: 2192861.
DOI: 10.1084/jem.184.5.1879.
The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen.
Mullbacher A
J Exp Med. 1994; 179(1):317-21.
PMID: 8270876
PMC: 2191322.
DOI: 10.1084/jem.179.1.317.
H-2-linked control of resistance to ectromelia virus infection in B10 congenic mice.
ONeill H, Blanden R, ONeill T
Immunogenetics. 1983; 18(3):255-65.
PMID: 6311733
DOI: 10.1007/BF00952964.
Neonatal tolerance of major histocompatibility complex antigens alters Ir gene control of the cytotoxic T cell response to vaccinia virus.
Mullbacher A, Blanden R, Brenan M
J Exp Med. 1983; 157(4):1324-38.
PMID: 6220111
PMC: 2186975.
DOI: 10.1084/jem.157.4.1324.
Persistence of cell-mediated immunity to influenza A virus in mice.
Ashman R
Immunology. 1982; 47(1):165-8.
PMID: 6214498
PMC: 1555495.
The immune response to vaccinia virus infection in mice: analysis of the role of antibody.
Novembre F, RASKA Jr K, Holowczak J
Arch Virol. 1989; 107(3-4):273-89.
PMID: 2684096
DOI: 10.1007/BF01317923.
Poxvirus pathogenesis.
Buller R, Palumbo G
Microbiol Rev. 1991; 55(1):80-122.
PMID: 1851533
PMC: 372802.
DOI: 10.1128/mr.55.1.80-122.1991.
Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.
Littaua R, Takeda A, Cruz J, Ennis F
J Virol. 1992; 66(4):2274-80.
PMID: 1548761
PMC: 289021.
DOI: 10.1128/JVI.66.4.2274-2280.1992.
Delayed-type hypersensitivity against Semliki Forest virus in mice.
Kraaijeveld C, Harmsen M
Infect Immun. 1979; 23(2):219-23.
PMID: 422238
PMC: 414151.
DOI: 10.1128/iai.23.2.219-223.1979.
Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.
Dunlop M
Immunology. 1978; 34(2):291-302.
PMID: 304841
PMC: 1457696.
Cytotoxic T cell response to lymphocytic choriomeningitis virus. Properties of precursors of effector T cells, primary effector T cells and memory T cells in vitro and in vivo.
Dunlop M, Doherty P, Zinkernagel R, Blanden R
Immunology. 1977; 33(3):361-8.
PMID: 302823
PMC: 1445661.
Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.
Perrin L, Zinkernagel R, Oldstone M
J Exp Med. 1977; 146(4):949-69.
PMID: 302316
PMC: 2180809.
DOI: 10.1084/jem.146.4.949.
Cytotoxic T cells specific for influenza virus-infected target cells.
Yap K, Ada G
Immunology. 1977; 32(2):151-9.
PMID: 300355
PMC: 1445215.
A T helper cell for anti-viral cytotoxic T-cell responses.
Ashman R, Mullbacher A
J Exp Med. 1979; 150(5):1277-82.
PMID: 227982
PMC: 2185695.
DOI: 10.1084/jem.150.5.1277.
Primary anti-viral cytotoxic T-cell responses in semiallogeneic chimeras are not absolutely restricted to host H-2 type.
Blanden R, Andrew M
J Exp Med. 1979; 149(2):535-8.
PMID: 216768
PMC: 2184800.
DOI: 10.1084/jem.149.2.535.
Specific adsorption of H-2-restricted cytotoxi T cells to macrophage monolayers.
Kees U, Mullbacher A, Blanden R
J Exp Med. 1978; 148(6):1711-5.
PMID: 214513
PMC: 2185098.
DOI: 10.1084/jem.148.6.1711.
